FDA Inspection 1268372 — Guilin China Resources Tianhe Pharmaceutical Co., Ltd.
The FDA completed an inspection of Guilin China Resources Tianhe Pharmaceutical Co., Ltd. on March 28, 2025 in Guilin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 28, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Guilin (China)